827 related articles for article (PubMed ID: 31193998)
21. Remote versus in-office monitoring for implantable cardioverter defibrillators: Results from a randomized pragmatic controlled study in Portugal.
Oliveira M; Fernandes M; Reis H; Primo J; Sanfins V; Silva V; Cunha PS; Silva M; Nicola PJ;
Rev Port Cardiol; 2022 Dec; 41(12):987-997. PubMed ID: 36229282
[TBL] [Abstract][Full Text] [Related]
22. Burden of Implanted-Device-Detected Atrial High-Rate Episode Is Associated With Future Heart Failure Events - Clinical Significance of Asymptomatic Atrial Fibrillation in Patients With Implantable Cardiac Electronic Devices.
Nishinarita R; Niwano S; Fukaya H; Oikawa J; Nabeta T; Matsuura G; Arakawa Y; Kobayashi S; Shirakawa Y; Horiguchi A; Nakamura H; Ishizue N; Kishihara J; Satoh A; Ako J
Circ J; 2019 Mar; 83(4):736-742. PubMed ID: 30814400
[TBL] [Abstract][Full Text] [Related]
23. Impact of remote monitoring on clinical outcomes for patients with heart failure and atrial fibrillation: results from the REM-HF trial.
Zakeri R; Morgan JM; Phillips P; Kitt S; Ng GA; McComb JM; Williams S; Wright DJ; Gill JS; Seed A; Witte KK; Cowie MR;
Eur J Heart Fail; 2020 Mar; 22(3):543-553. PubMed ID: 31908129
[TBL] [Abstract][Full Text] [Related]
24. Disease management: atrial fibrillation and home monitoring.
Ricci RP
Europace; 2013 Jun; 15 Suppl 1():i35-i39. PubMed ID: 23737228
[TBL] [Abstract][Full Text] [Related]
25. Economic analysis of remote monitoring in patients with implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators in the Trento area, Italy.
Marini M; Videsott L; Dalle Fratte CF; Francesconi A; Bonvicini E; Quintarelli S; Martin M; Guarracini F; Coser A; Benetollo PP; Bonmassari R; Boriani G
Front Cardiovasc Med; 2023; 10():1151167. PubMed ID: 37304964
[TBL] [Abstract][Full Text] [Related]
26. Remote Monitoring for Chronic Disease Management: Atrial Fibrillation and Heart Failure.
Ono M; Varma N
Card Electrophysiol Clin; 2018 Mar; 10(1):43-58. PubMed ID: 29428141
[TBL] [Abstract][Full Text] [Related]
27. Fluid status monitoring with a wireless network to reduce cardiovascular-related hospitalizations and mortality in heart failure: rationale and design of the OptiLink HF Study (Optimization of Heart Failure Management using OptiVol Fluid Status Monitoring and CareLink).
Brachmann J; Böhm M; Rybak K; Klein G; Butter C; Klemm H; Schomburg R; Siebermair J; Israel C; Sinha AM; Drexler H;
Eur J Heart Fail; 2011 Jul; 13(7):796-804. PubMed ID: 21555324
[TBL] [Abstract][Full Text] [Related]
28. Randomized Clinical evaluatiON of wireless fluid monitoriNg and rEmote ICD managemenT using OptiVol alert-based predefined management to reduce cardiac decompensation and health care utilization: the CONNECT-OptiVol study.
Zabel M; Vollmann D; Lüthje L; Seegers J; Sohns C; Zenker D; Hasenfuss G
Contemp Clin Trials; 2013 Jan; 34(1):109-16. PubMed ID: 23073567
[TBL] [Abstract][Full Text] [Related]
29. Role of Remote Monitoring in Detection of Atrial Arrhythmia, Stroke Reduction, and Use of Anticoagulation Therapy - A Systematic Review and Meta-Analysis.
Jang JP; Lin HT; Chen YJ; Hsieh MH; Huang YC
Circ J; 2020 Oct; 84(11):1922-1930. PubMed ID: 33012748
[TBL] [Abstract][Full Text] [Related]
30. The impact of remote monitoring of implanted cardioverter-defibrillator (ICD) and cardiac resynchronisation therapy device (CRT-D) patients on healthcare costs in the Silesian population: three-year follow-up.
Buchta P; Tajstra M; Kurek A; Skrzypek M; Świetlińska M; Gadula-Gacek E; Wasiak M; Pyka Ł; Gąsior M
Kardiol Pol; 2017; 75(6):573-580. PubMed ID: 28150288
[TBL] [Abstract][Full Text] [Related]
31. [Device-based remote monitoring : Current evidence].
Duncker D; Michalski R; Müller-Leisse J; Zormpas C; König T; Veltmann C
Herzschrittmacherther Elektrophysiol; 2017 Sep; 28(3):268-278. PubMed ID: 28812129
[TBL] [Abstract][Full Text] [Related]
32. Temporal Association of Atrial Fibrillation With Cardiac Implanted Electronic Device Detected Heart Failure Status.
Capucci A; Wong JA; Gold MR; Boehmer J; Ahmed R; Kwan B; Thakur PH; Zhang Y; Jones PW; Healey JS
JACC Clin Electrophysiol; 2022 Feb; 8(2):182-193. PubMed ID: 35210075
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial.
Varma N; Epstein AE; Irimpen A; Schweikert R; Love C;
Circulation; 2010 Jul; 122(4):325-32. PubMed ID: 20625110
[TBL] [Abstract][Full Text] [Related]
34. Effects of remote monitoring of cardiac implantable electronic devices after stroke or transient ischemic attack.
De Simone V; Zanotto G; Guarise P; Venturato A; Cassinadri E; Bassi M; Bozzolin M; Tondelli S; Giacopelli D; Morando G
J Cardiovasc Med (Hagerstown); 2019 Aug; 20(8):551-556. PubMed ID: 31157660
[TBL] [Abstract][Full Text] [Related]
35. Potential role of remote monitoring for scheduled and unscheduled evaluations of patients with an implantable defibrillator.
Heidbüchel H; Lioen P; Foulon S; Huybrechts W; Ector J; Willems R; Ector H
Europace; 2008 Mar; 10(3):351-7. PubMed ID: 18245771
[TBL] [Abstract][Full Text] [Related]
36. Remote Monitoring of Heart Failure in Patients with Implantable Cardioverter-Defibrillators: Current Status and Future Needs.
Theuns DAMJ; Radhoe SP; Brugts JJ
Sensors (Basel); 2021 May; 21(11):. PubMed ID: 34071624
[TBL] [Abstract][Full Text] [Related]
37. Rationale, design, and baseline characteristics of a Program to Assess and Review Trending INformation and Evaluate CorRelation to Symptoms in Patients with Heart Failure (PARTNERS HF).
Whellan DJ; O'Connor CM; Ousdigian KT; Lung TH;
Am Heart J; 2008 Nov; 156(5):833-9, 839.e2. PubMed ID: 19061695
[TBL] [Abstract][Full Text] [Related]
38. Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) trial.
Varma N; Michalski J; Epstein AE; Schweikert R
Circ Arrhythm Electrophysiol; 2010 Oct; 3(5):428-36. PubMed ID: 20716717
[TBL] [Abstract][Full Text] [Related]
39. Impact of Remote Monitoring on Clinical Outcomes.
Varma N; Ricci RP
J Cardiovasc Electrophysiol; 2015 Dec; 26(12):1388-95. PubMed ID: 26337400
[TBL] [Abstract][Full Text] [Related]
40. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
Young JB; Abraham WT; Smith AL; Leon AR; Lieberman R; Wilkoff B; Canby RC; Schroeder JS; Liem LB; Hall S; Wheelan K;
JAMA; 2003 May; 289(20):2685-94. PubMed ID: 12771115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
